Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Burkitt Lymphoma 1

Interventions

fludarabine phosphate 52Cyclophosphamide 52Peripheral Blood Stem Cell Transplantation 50Rituximab 47Mycophenolic Acid 34Whole-Body Irradiation 33Tacrolimus 26Cyclosporine 25Busulfan 23Etoposide 21Filgrastim 19Methotrexate 18Melphalan 18Antilymphocyte Serum 18Radiotherapy 15Bortezomib 15Sirolimus 12Lenalidomide 11ibrutinib 9Flow Cytometry 9Cyclosporins 9Everolimus 8Dexamethasone 8Carboplatin 8sargramostim 7Polymerase Chain Reaction 7Methylprednisolone 7Indium 7Cytarabine 7idelalisib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Waldenstrom Macroglobulinemia × Lapatinib × Other hematologic neoplasm × Clear all
NCT00352443 2015-03-06

S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

SWOG Cancer Research Network

Phase 1 Completed
66 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡